AEM3-1251 | UAT | Webinar pagination does not work – 2

Abigail Guce-Merriam leads the downstream process development, located in our Burlington, MA, facility. Her group mainly focuses on client molecule downstream process development, process tech transfers to GMP production, and DS formulation study.

A biophysicist and structural biologist by training, she holds a Ph.D. from the University of Massachusetts-Amherst. Prior to joining the company in 2018, Abby was a downstream process development SME and protein purification expert in MassBiologics (CDMO) and UMASS Medical School Structural Lab.

Adam Jakus, Ph.D. is the co-founder and Chief Technology of Dimension Inx, LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Adam received his BS and MS degrees in Materials Science and Engineering from Georgia Tech, where he worked on the development and testing of new energetic material systems. In 2010, he began working at Northwestern University with Dimension Inx’s other co-founder, Ramille Shah, Ph.D. While at Northwestern, Adam invented and developed an entirely new, materials-centric approach to 3D-printing and advanced manufacturing, now referred to as 3D-Painting, and hundreds of new 3D-printable materials for medical and non-medical purposes. These materials include, but are not limited to the high tissue and organ regenerative Hyperelastic Bone™, 3D-Graphene, Tissue Papers, and Fluffy-X. With approximately 10 years and many thousands of hours of bioprinting and tissue regenerative 3D-Printing experience, Adam leads the field, providing expertise to several not-for-profit bodies looking to establish guidelines, guidance, and certifications related to the emerging fields of tissue and organ fabrication. He is the author of numerous granted and pending patents, high impact medical and non-medical publications, book chapters, and editorials related to advanced manufacturing and 3D-printing of biomaterials and non-materials.